RGS1 presents a close relationship with neuroinflammation by responding to diverse chemokines (Balashov et al., 1999) and was recently designated as an MS susceptibility locus by the International Multiple Sclerosis Genetics Consortium (International Multiple Sclerosis Genetics Consortium, 2010). This evidence concerns the gene RGS1 and myeloid sarcoma.